Renal Group
The Director of U.S. Public Policy develops and executes policy strategies to advance market access, coverage, coding, and payment for the company's medical device and drug portfolio. This role serves as the lead policy expert on federal healthcare reimbursement, primarily focusing on CMS and Medicare payment systems, while influencing policymakers and stakeholders to support patient access to innovative technologies. The position requires deep expertise in healthcare financing and regulatory policy to align policy strategy with organizational objectives.
At the Renal Group, we are strong advocates for your health as we continually explore new medicines and technologies. We provide treatment in Nephrology and Hypertension.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Renal Group.
89% above the average for this role
Director, Market Access – CMS Coverage & Reimbursement Policy
Illumina
Director, Government Affairs - U.S. Reimbursement
AbbVie
Executive Director, U.S. Public Policy (CMS, HHS & Payment Policy)
BridgeBio Pharma
Director, Government Affairs - U.S. Reimbursement
AbbVie
Director, Government Affairs - U.S. Reimbursement
AbbVie
Director, Government Affairs - U.S. Reimbursement
AbbVie